We describe the case of a 43-year-old primiparous woman who had acute myocardial infarction. She underwent successful primary percutaneous coronary intervention. Elective cesarean section was performed uneventfully at 32 weeks gestation.
Introduction

Acute myocardial infarction (AMI) during pregnancy is a rare but serious condition, based on the danger of maternal mortality and fetal loss. Pregnancy has been shown to increase the risk of AMI about 3-to 4-fold (1). The incidence of AMI in pregnancy is expected to increase, due to the trend for childbearing at older ages and advances in reproductive technology, which enable many older women to conceive (2).
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F i g u r e 1 . T h e e l e c t r o c a r d i o g r a m s h o we d S T e l e v a t i o n i n l e a d s V1 -V6 .
F i g u r e 2 . L e f t c o r o n a r y a n g i o g r a p h y ( RAO c r a n i a l ) . A) T o t a l o c c l u s i o n wi t h t h r o mb u s o f t h e p r o x i ma l L AD. B ) S u c c e s s f u l P CI u s i n g a s p i r a t i o n t h r o mb e c t o my a n d a b a r e -me t a l s t e n t . RAO: r i g h t a n t e r i o r o b l i q u e , L AD: l e f t a n t e r i o r d e s c e n d i n g c o r o n a r y a r t e r y , P CI : p e r c u t a n e o u s c o r on a r y i n t e r v e n t i o n wall with reduced left ventricular (LV) systolic function [LV ejection fraction (EF) 49%, LV dimension in end-
Discussion
Pregnancy-associated AMI, which has been reported to occur in 3-10 cases per 100,000 deliveries, is rare (1, 3, 4) . A previous review demonstrated that pregnancy-associated AMI occurred at all stages of pregnancy and more commonly late in pregnancy, with a peak incidence during the peripartum or postpartum period (5) . In the present case, the event occurred relatively early in the second trimester of pregnancy. The incidence of mortality in women who have been diagnosed with AMI during the peripartum period is twice as high as those who have been diagnosed in the antepartum and postpartum periods (3, 5) .
A (4) (8) 
previous review revealed a relatively high incidence of known risk factors for AMI in patients with pregnancy-associated AMI, despite their young ages. Most of these patients (72%) were older than 30 years (range 19 to 44 years). Ladner et al (3) identified hypertension, diabetes, advanced maternal age, preeclampsia, and eclampsia as independent risk factors for pregnancy-associated AMI, and James et al
Recent recommendations for drug therapy in non-pregnant patients with AMI include the use of heparin, aspirin and clopidogrel (6). Heparin does not cross the placenta, and several reports have demonstrated that heparin is safe to use during pregnancy (7). A meta-analysis
